What is a GLP-1 medication?

GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes that have shown significant weight-loss benefits. They mimic a naturally occurring hormone that regulates appetite, slows stomach emptying, and helps control blood sugar. Common brand names include Ozempic, Wegovy, Mounjaro, and Zepbound.

How much weight can I lose on GLP-1 medications?

Clinical trials show that GLP-1 medications can lead to 15–22% body weight loss over 68 weeks when combined with lifestyle changes. Individual results vary based on dosage, diet, activity level, and adherence.

What should I eat while taking GLP-1 medications?

Prioritize high-protein foods to preserve muscle mass, fiber-rich vegetables for digestion, and adequate hydration. Avoid high-fat, fried, and very sugary foods, which can worsen nausea and other GI side effects.

What are the most common GLP-1 side effects?

The most frequently reported side effects are nausea, vomiting, diarrhea, constipation, and fatigue. These typically occur during dose escalation and subside as your body adjusts.

Do I need to exercise while on GLP-1s?

Yes. Strength training is especially important to preserve muscle mass during weight loss — without it, up to 40% of weight lost can be muscle. Aim for 2–3 resistance training sessions per week plus moderate cardio.

How do I track my GLP-1 progress effectively?

Tracking medication doses, side effects, nutrition (especially protein), weight, and workouts gives you and your doctor a complete picture. OptimizeGLP was built specifically for this — it logs injections, calculates protein targets, tracks side effects, visualizes progress, and generates weekly summaries.

OptimizeGLP links meal plans, medication logs, food databases, medications, and referrals in 142 pages for weight goals, workouts, and reminders.

All Articles

Ozempic vs Mounjaro: Which GLP-1 is Better?

A single GLP-1 agonist vs a dual GIP/GLP-1 agonist — different mechanisms, different results. Here's how they compare.

7 min read · Educational resource

The Short Answer

Ozempic (semaglutide) is a single GLP-1 receptor agonist, while Mounjaro (tirzepatide) is a dual GIP/GLP-1 agonist. Mounjaro's dual mechanism produces greater weight loss in clinical trials (~20% vs ~14%), but both are effective. Both are FDA-approved for type 2 diabetes.

Side-by-Side Comparison

Feature	Ozempic	Mounjaro
Active Ingredient	Semaglutide	Tirzepatide
Drug Class	GLP-1 Agonist	GIP/GLP-1 Dual Agonist
Manufacturer	Novo Nordisk	Eli Lilly
FDA Approval	Type 2 Diabetes	Type 2 Diabetes
Max Dose	2.0 mg weekly	15 mg weekly
Administration	Weekly injection	Weekly injection
Avg Weight Loss	~10-14%	~20%
Mechanism	Targets GLP-1 receptor	Targets GIP + GLP-1 receptors

Key Differences

Mounjaro's dual-agonist mechanism (GIP + GLP-1) produces significantly more weight loss than Ozempic's single GLP-1 mechanism
Mounjaro reaches a higher max dose (15 mg vs 2.0 mg), though the drugs aren't directly comparable by dose since they're different molecules
Both are FDA-approved for type 2 diabetes, so insurance coverage is often similar for diabetic patients
Side effect profiles are similar (GI-focused), but Mounjaro may cause slightly more nausea during titration due to its stronger effect

Which Should You Choose?

💉

Choose Ozempic

Choose Ozempic if you want a well-established GLP-1 with a long safety track record. It's an excellent choice for blood sugar control and moderate weight loss, and may be preferred if you've tolerated semaglutide well before.

Full Ozempic Guide

🏔️

Choose Mounjaro

Choose Mounjaro if you want the maximum weight loss available from a GLP-1 medication. Its dual mechanism produces roughly 50% more weight loss than Ozempic in head-to-head trials.

Full Mounjaro Guide

Other Medication Comparisons

💉🎯

Ozempic vs Wegovy

6 min read

🏔️⚡

Mounjaro vs Zepbound

6 min read

🎯⚡

Wegovy vs Zepbound

7 min read

💊💉

Rybelsus vs Ozempic

6 min read

Frequently Asked Questions

Is Mounjaro stronger than Ozempic?

In clinical trials, tirzepatide (Mounjaro) produces roughly 50% more weight loss than semaglutide (Ozempic) — about 20% vs 14% of body weight. This is because Mounjaro targets two hormone receptors (GIP and GLP-1) while Ozempic targets only one (GLP-1). However, "stronger" doesn't mean better for everyone — side effects and individual response vary.

Can I switch from Ozempic to Mounjaro?

Yes, switching is common and done under your doctor's guidance. Since they're different molecules, there's no direct dose equivalent. Your doctor will likely start Mounjaro at its beginning dose (2.5 mg) and titrate up, even if you were on a higher Ozempic dose. Never switch on your own.

Do they have the same side effects?

Both cause primarily gastrointestinal side effects (nausea, diarrhea, constipation, vomiting). The side effect profiles are similar, but because Mounjaro is more potent, some patients experience slightly more intense side effects during titration. Both have the same serious risks to discuss with your doctor.

Which is better for weight loss?

Mounjaro produces more weight loss in clinical trials (~20% vs ~14%). If maximum weight loss is your goal and you don't have a reason to prefer semaglutide, Mounjaro may be the better choice. However, individual response varies, and some patients do very well on Ozempic. Discuss with your doctor.

Ready to put this into practice?

OptimizeGLP tracks your medication, nutrition, side effects, and progress — all in one place, built for GLP-1 patients.

Get Started Free Try the Protein Calculator →